Genentech, Roche Break Ground on N.C. Manufacturing Facility | Press Releases
U.S. Rep. Deborah Ross; Susanne Hundsbæk-Pedersen, global head of pharma technical operations and EVP at Roche; North Carolina…
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
– Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with…
Is FDA’s Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)?
In December 2025, Genentech, part of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a…
Swiss drugmaker Roche leans into Trump tariff formula with $50bn promise to invest in U.S.
Swiss pharmaceutical giant Roche has promised to export more medicine from the U.S. than it imports once a…
Roche’s Genentech more than doubles North Carolina facility investment to $2B
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free…